Appili Therapeutics Inc. APLIF
Set alert
0.01 USD 0.00 0.00%
At close · Oct 30
0.004 Day range 0.007
0.004 52-week range 0.02
- YTD
- -53.33%
- 1 year
- -61.11%
- Open
- 0.007
- Prev close
- 0.007
- Mkt cap
- 926.56K
- Vol
- 36.65K
- Avg vol
- 5.49K
- EPS
- -0.04
- P/E
- -0.17
More statistics
- Low
- 0.004
- High
- 0.007
- Earnings
- Feb 11, 2025
2Y chart
Events in this range
- Nov 14, 2024Earnings: 0; estimate 0; surprise —%
- Feb 11, 2025Earnings: —; estimate 0; surprise —%
Signals (130)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| RSI: Oversold | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 3, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| RSI: Oversold | Aug 31, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 17, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 10, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 24, 2026 | 4 months ago |
| SMA: Bearish | Jun 23, 2026 | 4 months ago |
| SMA: Bearish | Jun 23, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| RSI: Oversold | Jun 12, 2026 | 4 months ago |
| SMA: Bearish | May 22, 2026 | 5 months ago |
| SMA: Bearish | May 22, 2026 | 5 months ago |
Newest 20 of 130.
Next earnings
Feb 11, 2025
Expected Feb 11, 2025. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2025 | Dec 1, 2024 | 0.00 | — | — | — |
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | -0.01 | — | — |
| Jun 25, 2024 | Mar 1, 2024 | -0.01 | -0.01 | 0.00 | 0.00% |
| Feb 13, 2024 | Dec 1, 2023 | -0.01 | 0.00 | — | — |
| Nov 13, 2023 | Sep 1, 2023 | -0.01 | -0.01 | 0.00 | 0.00% |
News
- Appili Therapeutics Announces Transfer to NEX
- Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2027
- Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
- Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
- Appili Therapeutics to Exhibit at World Vaccine Congress Washington
- Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement
- Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
- Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
- Appili Therapeutics to Attend BARDA Innovation Symposium 2025
- Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01
Your note
Sign in to keep a note on APLIF — it syncs with the Stock Master app.